'Saizen' http://www.humangrowthhormones.biz/saizen.xml/ 2008-11-20T19:29:02+01:00 text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----merck-serono-and-flamel-to-collaborate-on-an-extended-release-formulation-for-therapeutic-proteins December 20, 2007 -- Flamel's Medusa([R]) technology designed to allow less frequent administration of therapeutic proteins and peptides LYON, France -- Flamel... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----introducing-the-brand-new-report-on-business-strategies-for-different-types-of-biogenerics December 6, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76537) has announced the addition of new Decision Resources... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#pr-newswire-europe----fda-approval-of-easypod(r):-new-electronic-growth-hormone-injection-device. November 8, 2007 -- GENEVA, Switzerland, November 8 /PRNewswire/ -- - Innovative Device Designed for Simple Everyday Use by Patients and Caregivers Merck... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----to-date,-only-one-recognisably-biosimilar-drug,-human-growth-hormone,-has-appeared-in-developed-markets:-will-a-significant-biosimilar-market-develop? September 13, 2006 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42003) has announced the addition of Espicom Business Analysis's... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----rodman-&-renshaw-3rd-annual-global-healthcare-conference-2006-presenter-profiles May 12, 2006 -- MONTE CARLO, Monaco -- Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 takes place May 15-16 in Monte Carlo. For in-depth... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#worldwide-biotech----serono's-gonal-f-approved-in-japan-for-hypogonadism March 1, 2006 -- Serono (virt-x: SEO and NYSE: SRA) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Gonal-f(R) 75 IU and... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#internal-medicine-news----growth-hormone-replacement October 1, 2004 -- Saizen (somatropin [rDNA origin] for injection) is indicated for long-term growth hormone replacement in adults with confirmed growth hormone... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----serono-and-ivax-announce-positive-outcome-of-pharmacokinetic-trials-with-oral-cladribine March 23, 2004 -- Business Editors/Health/Medical Writers GENEVA & MIAMI--(BUSINESS WIRE)--March 23, 2004 Cladribine Targeted to Become First Oral Therapy for... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----zymogenetics-and-serono-initiate-clinical-trial-with-taci-ig September 29, 2003 -- Business Editors/Health/Medical Writers SEATTLE & GENEVA--(BUSINESS WIRE)--Sept. 29, 2003 Inhibitor of B-cell Activation Provides Novel... text/html http://www.humangrowthhormones.biz/human-growth-hormone/saizen.xml/#business-wire----serono-and-ivax-to-develop-oral-therapy-for-multiple-sclerosis October 30, 2002 -- Business Editors/Health & Medical Writers GENEVA, Switzerland & MIAMI--(BUSINESS WIRE)--Oct. 30, 2002 Serono S.A. (virt-x: SEO)...